Jump to content

Tom Galli

Moderators
  • Content Count

    2,323
  • Joined

  • Last visited

  • Days Won

    369

Tom Galli last won the day on October 13

Tom Galli had the most liked content!

About Tom Galli

Profile Information

  • City
    Rockwall
  • US State (if applicable)
    TEXAS
  • Country
    US
  • Gender
    Male
  • Status
    Lung cancer patient/survivor
  • Interests
    Author of Scanziety, an ebook published on Amazon. Scanziety: A Retrospection of a Lung Cancer Survivor https://www.amazon.com/dp/B01JMTX0LU/ref=cm_sw_r_cp_api_i_g3pbDbH0T8E64
    Treatment history https://sites.google.com/a/redtoenail.org/chronicles-demo/home/tom-galli

Recent Profile Visitors

8,845 profile views
  1. Lin, I had a very good friend and high school alumni who was diagnosed with very treatable lung cancer. He got hooked by a “snake oil” salesman and very expensive but worthless “treatment”. Sadly, he passed, quickly. By the time he embraced science-based medicine, it was too late. I don’t know if marijuana is a lung cancer remedy. There have been no trials, no scientific research, and consequently no data. The import of science-based treatment is that results are repeatable. Immunotherapy is new. I wouldn’t do anything that might affect its treatment impact. It has dramatically moved the survival needle. Don’t introduce something that may compromise your best chance at survival. Stay the course. Tom
  2. Marie, I forgot to tell you. Keep him far away from school aged children. A chest cold at this stage is a nightmare! Stay the course. Tom
  3. Let's see some pictures..... Stay the course. Tom
  4. Kristin, I'm going! Who else will attend this superb event? Stay the course. Tom
  5. Survivors and Care Givers, For Texans and anyone proximate to the Dallas--Fort Worth area, I'm hosting my first Lunch and Learn on Saturday, November 9th in Plano Texas. Here are the registration details. I'd love to meet all of you in person so if your schedule allows, come on down to Plano all you all! Stay the course. Tom
×
×
  • Create New...